BlackRock Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 40 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$2,907,180
-82.6%
3,126,000
-82.8%
0.00%
Q1 2023$16,679,545
-0.4%
18,126,000
-1.7%
0.00%
-100.0%
Q4 2022$16,750,813
+28.0%
18,446,000
+27.5%
0.00%
Q3 2022$13,082,000
+175.7%
14,466,000
+167.8%
0.00%
Q2 2022$4,745,000
+35.7%
5,401,000
+38.5%
0.00%
Q1 2022$3,497,000
+7.9%
3,901,000
+7.6%
0.00%
Q4 2021$3,241,000
-10.6%
3,626,000
-8.8%
0.00%
Q3 2021$3,626,000
-1.3%
3,976,000
+0.6%
0.00%
Q2 2021$3,672,000
+11.0%
3,951,000
+14.0%
0.00%
Q1 2021$3,308,000
+32.3%
3,465,000
+41.4%
0.00%
Q4 2020$2,500,0002,450,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opti Capital Management, LP 42,313,000$37,738,0003.63%
DeepCurrents Investment Group LLC 78,898,000$69,839,0002.79%
STEELHEAD PARTNERS LLC 31,350,000$27,716,0002.38%
Sonora Investment Management Group, LLC 20,200,000$17,734,0001.68%
Penn Mutual Asset Management, LLC 1,256,000$1,103,0001.49%
TENOR CAPITAL MANAGEMENT Co., L.P. 64,271,000$57,050,0001.28%
CAMDEN ASSET MANAGEMENT L P /CA 21,346,000$18,752,0000.58%
AVIVA PLC 60,265,000$52,901,0000.28%
OAKTREE CAPITAL MANAGEMENT LP 24,313,000$21,480,0000.25%
ADVENT CAPITAL MANAGEMENT /DE/ 13,680,000$12,086,0000.21%
View complete list of IONIS PHARMACEUTICALS INC shareholders